Zobrazeno 1 - 10
of 48
pro vyhledávání: '"AO Pasternak"'
Autor:
O Erlwein, A Winston, Peter Reiss, J Villaudy, B Berkhout, M. van der Valk, DP Benschop, A Kalsbeek, Ben Berkhout, M Martens, C Kingsley, T Booiman, Neeltje A. Kootstra, M Wezel, M Moreno-Villanueva, Paolo Garagnani, N Doyle, S Salvioli, BC Elsenga, JA ter Stege, T van der Kuyl, T Su, FR Janssen, BA Schmand, MM Mangas Ruiz, T Sindlinger, I Maurer, A Bürkle, M Capri, W Zikkenheiner, C Libert, M Chiricolo, Robert Leech, Ferdinand Wnm Wit, J Pothof, Caroline A. Sabin, Cblm Majoie, M Gisslén, A Lovell, Mmj Hillebregt, S Zaheri, I Visser, Claudio Franceschi, M de Graaff-Teulen, Alexander O. Pasternak, S Kovalev, M Prins, M Totté, NA Kootstra, H Zetterberg, D de Francesco, JH Cole, K Legg, Mwa Caan, J Schouten, M Klein Twennaar, Jelmer Vroom, J Berkel, AF Girigorie, P Reiss, S Moll, S Dewaele, K Weijer, D Fuchs, Marijn de Bruin, Alan Winston, Chiara Pirazzini, R.A. van Zoest, F Dall'Olio, Davide De Francesco, David J. Sharp, A Keller, AM Harskamp-Holwerda, J Underwood, F. W. Wit, GJ Geurtsen, P Portegies, Ymc Ruijs, M Stott, Margreet Bakker, M Heidenrijk, KW Kooij, Phlt Bisschop, G Guaraldi, L McDonald, C Sabin, AO Pasternak, J Hoeijmakers, Jan M. Prins, HG Ruhé, E Frankin, D Burger
Publikováno v:
eLife, Vol 10 (2021)
Elife, 10
Elife, 10
Background:It remains unclear whether combination antiretroviral therapy (ART) regimens differ in their ability to fully suppress human immunodeficiency virus (HIV) replication. Here, we report the results of two cross-sectional studies that compared
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3be576c147490052df3a9ceab70063d7
https://doi.org/10.7554/eLife.68174
https://doi.org/10.7554/eLife.68174
Autor:
Av, Giliazova, Pv, Zenin, Pronin AIu, Il, Serkov, Km, Khametova, Ea, Orlova-Morozova, Ev, Zhukova, Gv, Kornilaeva, Ao, Pasternak, Vv, Lukashov, E.V. Karamov
Publikováno v:
Europe PubMed Central
The Moscow Region is one of the HIV-1-affected subjects of the Russian Federation; there were 34613 HIV-1-infected subjects as of October 31, 2009. To characterize the molecular epidemiology of HIV-1 in the Moscow Region, the investigators obtained a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d2bc24629c05f1d64ba2b0a0f9d0d9eb
https://pubmed.ncbi.nlm.nih.gov/21260992
https://pubmed.ncbi.nlm.nih.gov/21260992
Autor:
Giron LB; Northwestern University, Chicago, Illinois, USA., Pasternak AO; Amsterdam UMC, University of Amsterdam, Laboratory of Experimental Virology, Department of Medical Microbiology and Infection Prevention, Amsterdam, Netherlands., Abdel-Mohsen M; Northwestern University, Chicago, Illinois, USA.
Publikováno v:
Current opinion in HIV and AIDS [Curr Opin HIV AIDS] 2024 Sep 26. Date of Electronic Publication: 2024 Sep 26.
Autor:
Fombellida-Lopez C; Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Laboratory of Immunology and Infectious Diseases, GIGA-Institute, University of Liège., Berkhout B; Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Darcis G; Laboratory of Immunology and Infectious Diseases, GIGA-Institute, University of Liège.; Department of General Internal Medicine and Infectious Diseases, University Hospital of Liège, Liège, Belgium., Pasternak AO; Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
Current opinion in HIV and AIDS [Curr Opin HIV AIDS] 2024 May 01; Vol. 19 (3), pp. 124-132. Date of Electronic Publication: 2024 Mar 12.
Autor:
Pasternak AO; Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Tsukamoto T; Department of Health Informatics, Niigata University of Health and Welfare, Niigata, Japan., Berkhout B; Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
AIDS (London, England) [AIDS] 2023 Nov 15; Vol. 37 (14), pp. 2239-2241. Date of Electronic Publication: 2023 Oct 26.
Autor:
Riechert V; Department of Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany., Hein S; Division of Virology, Paul-Ehrlich-Institut, Langen, Germany., Visser M; Division of Haematology and Transfusion Medicine, Paul-Ehrlich-Institut, Langen, Germany., Zimmermann M; Institute for Transfusion Medicine, University Medicine Greifswald, Greifswald, Germany., Wesche J; Institute for Transfusion Medicine, University Medicine Greifswald, Greifswald, Germany., Adams PA; Division of Experimental Virology, Department of Medical Microbiology, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands., Theuerkauf SA; Department of Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany., Jamali A; Department of Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany., Wangorsch A; Department of Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany., Reuter A; Division of Allergology, Paul-Ehrlich-Institut, Langen, Germany., Pasternak AO; Division of Experimental Virology, Department of Medical Microbiology, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands., Hartmann J; Department of Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany., Greinacher A; Institute for Transfusion Medicine, University Medicine Greifswald, Greifswald, Germany., Herrera-Carrillo E; Division of Experimental Virology, Department of Medical Microbiology, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands., Berkhout B; Division of Experimental Virology, Department of Medical Microbiology, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands., Cichutek K; Department of Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany., Buchholz CJ; Department of Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany. Electronic address: christian.buchholz@pei.de.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2023 Jun; Vol. 299 (6), pp. 104743. Date of Electronic Publication: 2023 Apr 24.
Autor:
Pasternak AO; Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands., Rohr O; Laboratoire de Dynamique des Interactions Hôte-Pathogènes EA7292, Université de Strasbourg, Schiltigheim, France.; Institut Universitaire de Technologie Louis Pasteur, Université de Strasbourg, Schiltigheim, France., Van Lint C; Service of Molecular Virology, Department of Molecular Biology, Université Libre de Bruxelles, Gosselies, Belgium., Kula-Pacurar A; Virogenetics Laboratory of Virology, Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.
Publikováno v:
Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2023 May 11; Vol. 13, pp. 1213356. Date of Electronic Publication: 2023 May 11 (Print Publication: 2023).
Autor:
Pasternak AO; Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands., Rohr O; Laboratoire de Dynamique des Interactions Hôte-Pathogènes EA7292, Université de Strasbourg, Schiltigheim, France.; Institut Universitaire de Technologie Louis Pasteur, Université de Strasbourg, Schiltigheim, France., Van Lint C; Service of Molecular Virology, Department of Molecular Biology, Université Libre de Bruxelles, Gosselies, Belgium., Kula-Pacurar A; Virogenetics Laboratory of Virology, Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.
Publikováno v:
Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2023 Apr 03; Vol. 13, pp. 1190867. Date of Electronic Publication: 2023 Apr 03 (Print Publication: 2023).
Autor:
Pasternak AO; Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands. Electronic address: a.o.pasternak@amsterdamumc.nl., Berkhout B; Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands.
Publikováno v:
Current opinion in virology [Curr Opin Virol] 2023 Apr; Vol. 59, pp. 101301. Date of Electronic Publication: 2023 Feb 17.
Autor:
Adams P; Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Berkhout B, Pasternak AO
Publikováno v:
Current opinion in HIV and AIDS [Curr Opin HIV AIDS] 2022 Sep 01; Vol. 17 (5), pp. 301-307. Date of Electronic Publication: 2022 Jul 05.